Why is Data Integrity Critical in the Pharma Industry?
In the global business environment, advancements in technology and digital platforms are changing how business operations are being carried out. The big data explosion has ensured that business and the digital platform become synonymous to enhance the productivity and efficiency of businesses.1 The economic and business possibilities of big data and its broader significance for social and technological advances become critical issues that business leaders should continuously consider. Across the pharmaceutical industry, this means that new frameworks of actions need to be adopted into business operations to reap the benefits associated with these technologies. Data integrity (DI) ensures that the data generated during business operations and drug manufacturing is accurate, complete and reliable.3, 4 Only when data is reliable can business owners make the best suitable choices for their organizations, improve the quality of their products and contribute to their overall success.
- 1. Roberta S. Russell & Bernard W. Taylor, Operations Management: creating a value among the supply chain, 7th Edition, ISBN-13 9780470525906 (2011)
- 3. ISPE GAMP® Guide: Records and Data Integrity (2017)
- 4. MHRA GxP Data Integrity Definitions and Guidance for Industry, Draft version for consultation (2016)